1. Home
  2. MEI vs CCCC Comparison

MEI vs CCCC Comparison

Compare MEI & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Methode Electronics Inc.

MEI

Methode Electronics Inc.

HOLD

Current Price

$13.40

Market Cap

398.2M

Sector

Technology

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$4.22

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEI
CCCC
Founded
1946
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
398.2M
404.7M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
MEI
CCCC
Price
$13.40
$4.22
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$9.00
$12.20
AVG Volume (30 Days)
580.8K
2.4M
Earning Date
03-05-2026
05-06-2026
Dividend Yield
2.61%
N/A
EPS Growth
49.14
16.45
EPS
N/A
N/A
Revenue
$908,300,000.00
$35,947,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.24
1.02
52 Week Low
$4.88
$1.40
52 Week High
$15.55
$4.60

Technical Indicators

Market Signals
Indicator
MEI
CCCC
Relative Strength Index (RSI) 62.78 62.91
Support Level $6.72 $2.10
Resistance Level $13.53 $4.60
Average True Range (ATR) 0.97 0.37
MACD 0.11 0.00
Stochastic Oscillator 73.21 77.88

Price Performance

Historical Comparison
MEI
CCCC

About MEI Methode Electronics Inc.

Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: